Mitochondrial Liver Toxicity of Valproic Acid and Its Acid Derivatives Is Related to Inhibition of α-Lipoamide Dehydrogenase
The liver toxicity of valproic acid (VPA) is an established side effect of this widely used antiepileptic drug, which is extremely problematic for patients with metabolic epilepsy and particularly epilepsy due to mitochondrial dysfunction. In the present report, we investigated the reason for liver...
Main Authors: | Alexei P. Kudin, Hafiz Mawasi, Arik Eisenkraft, Christian E. Elger, Meir Bialer, Wolfram s. Kunz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-09-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/18/9/1912 |
Similar Items
-
Valproic acid-associated pancytopenia: A dose-dependent adverse effect
by: Jamir Pitton Rissardo, et al.
Published: (2019-09-01) -
Frequency of Subclinic Hypothyroidism at the Patients That Are Using Valproic Acid
by: Mehmet Ibrahim Turan, et al.
Published: (2014-06-01) -
Effects of Valproic acid drug on Hepatic tissues in female mice
by: El-nagi O. M. El-nagaz, Tarek A. Guseibat, Omelaz A. M. Elturshani, Khalida R. Al-Sarraj, Amal El-Tarhouni
Published: (2020-10-01) -
Serum Leptin Levels in Epileptic Patients Treated with Topiramate and Valproic Acid
by: İrem Fatma Uludağ, et al.
Published: (2011-03-01) -
Long-Term Effectiveness of Ethosuximide, Valproic Acid and Lamotrigine in Absence Epilepsy
by: J Gordon Millichap
Published: (2012-06-01)